| 書目名稱 | The role of interleukin-2 in the treatment of cancer patients |
| 編輯 | John Wagstaff (Senior Lecturer in Medical Oncology |
| 視頻video | http://file.papertrans.cn/923/922570/922570.mp4 |
| 圖書封面 |  |
| 描述 | Recombinanthumaninterleukin-2 became available for clinicaluse in themid1980s. Recent years have seen an enormous amount ofclinical researchwith this cytokine and interleukin-2 has now beenregistered foruseinanumberofEuropeancountriesfor thetreatment of metastatic renal cell carcinoma.Thisbookisdesigned to provide the clinical oncologist wishing touseinterleukin-2witha basic background concerning the biology oftheagent, a discussion concerning practical aspects, of its clinicaluseincludingmanagement of toxicity and an overview of the clinicalresultstogether with a description of how this internesting cytokinemight be developed in the future. |
| 出版日期 | Book 1993 |
| 關(guān)鍵詞 | carcinoma; cell; cytokine; cytokines; lymphocytes; renal cell carcinoma; tumor |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-94-011-1753-1 |
| isbn_softcover | 978-94-010-4769-2 |
| isbn_ebook | 978-94-011-1753-1 |
| copyright | Springer Science+Business Media Dordrecht 1993 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-7 10:51
發(fā)表于 2025-3-21 16:09:04
